ACM Biolabs Pte LTD

11:30 AM - 11:45 AM (PDT), Thursday, June 16, 2022 ・ Company Presentation Theater 1
We are based in two world leading innovation hubs for biotechnology: Singapore and Switzerland. Embedded in a rich ecosystem of pharmaceutical companies, biotechs, and institutional and private investors, we believe this is a valuable success factor to advance our science and pipeline programs. Our experienced team with senior ex-pharma veterans provide a basis to attract talent, partners and investors.
As a dedicated team combining pharmaceutical industry, biotech, and academic excellence we develop prophylactic treatment and therapeutic vaccines for infectious diseases and therapeutic vaccines for personalized cancer treatment based on our proprietary polymer-based targeted delivery platform technology. Our platform technology, however, is not limited to vaccines.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Switzerland
Year Founded:
2013
Main Therapeutic Focus:
Lead Product in Development:
ACM-001
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided